Form 8-K · Current Report · Filed 2025-03-05
Kenvue Appoints New Directors and Enters Cooperation Agreement with Starboard
Kenvue Inc. has appointed three new directors to its Board of Directors as part of a cooperation agreement with Starboard Value LP. The agreement, effective immediately, expands the board size from 11 to 14 directors and includes provisions for board nominations at the 2025 Annual Meeting, standstill agreements, and committee assignments for the new directors. Starboard also agreed to withdraw its previously nominated director slate and vote its shares in favor of Kenvue's nominees. The agreement aims to strengthen the board with complementary expertise and facilitate the pursuit of growth and profitability.
- Filer
- Kenvue Inc. KVUE · NYSE
- Filed
- Accession
- 0001944048-25-000035
- CIK
- 0001944048
- Signal
- High impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Entry into a Material Definitive Agreement
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$23.42
Next session
-1.0%
Since filing
-17.8%
Latest close
$19.24
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from KVUE reporting the same item, with the next session's move:
Exhibits (2)
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Never miss another KVUE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.